Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...
Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...
Compass Pathways (NASDAQ:CMPS) executives outlined plans for a potential U.S. regulatory filing and commercial launch ...
Bigger is better, right? Well, maybe not always. Here are 10 cars powered by small-capacity, in-line six-cylinder engines.
All animal studies were performed according to protocols approved by the University Committee on Animal Resources at the University of Rochester Medical ...